 Brokerages forecast that Cellular Biomedicine Group Inc NASDAQ:CBMG will post 0.74 earnings per share for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have made estimates for Cellular Biomedicine Groups earnings. Cellular Biomedicine Group reported earnings of 0.63 per share during the same quarter last year, which would suggest a negative year ... 